Morley J E, Levine A S, Murray S S, Kneip J
Pharmacol Biochem Behav. 1982 Feb;16(2):225-8. doi: 10.1016/0091-3057(82)90152-6.
The inhibitory effect of a variety of substances on feeding induced by norepinephrine (20 micrograms ICV) was studied. Subcutaneous administration of opiate antagonist, naloxone, inhibited norepinephrine-induced eating at 10 and 5 mg/kg, but not a 1 mg/kg. Intraventricular administration of the GABA antagonist, bicuculline, produced a dose related decrease in food ingestion. The putative satiety hormones, bombesin (10 micrograms/kg; subcutaneously) and cholecystokinin octapeptide (10 micrograms/kg; subcutaneously) also reduced norepinephrine induced eating, as did ICV administration of calcitonin (2 units). Neither thyrotropin-releasing hormone (1 microgram ICV) nor its metabolits, histidyl-proline diketopiperazine (1 microgram ICV) altered norepinephrine-induced feeding. The studies reported here suggest a neuromodulatory role of peptides in the central regulation of norepinephrine-induced feeding.
研究了多种物质对去甲肾上腺素(20微克脑室内注射)诱导进食的抑制作用。皮下注射阿片拮抗剂纳洛酮,10毫克/千克和5毫克/千克剂量时可抑制去甲肾上腺素诱导的进食,但1毫克/千克剂量时无此作用。脑室内注射GABA拮抗剂荷包牡丹碱可使食物摄入量呈剂量相关减少。假定的饱腹感激素,蛙皮素(10微克/千克;皮下注射)和八肽胆囊收缩素(10微克/千克;皮下注射)也可减少去甲肾上腺素诱导的进食,脑室内注射降钙素(2单位)也有此作用。促甲状腺激素释放激素(1微克脑室内注射)及其代谢产物组氨酰-脯氨酸二酮哌嗪(1微克脑室内注射)均未改变去甲肾上腺素诱导的进食。此处报道的研究表明,肽在去甲肾上腺素诱导进食的中枢调节中起神经调节作用。